BMY vs RAMP · P/E 17, rev $24.46B vs rev $812.9M
Bristol-Myers Squibb Company (BMY) versus Liveramp Holdings Inc (RAMP) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Liveramp Holdings Inc (RAMP) is a software - infrastructure company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RAMP revenue for 2026-03-31 was $812.9M. Net income was $146.0M. Revenue was up 9.0% from 2025-03-31 to 2026-03-31. RAMP currently screens at market cap $2.19B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RAMP currently screens at market cap $2.19B.
Not investment advice. Open the BMY and RAMP stock pages for the full models.
Not investment advice.